Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study
Condition: Stenotrophomonas Infection Interventions: Drug: Levofloxacin; Drug: trimethoprim-sulfamethoxazole Sponsors: National Institutes of Health Clinical Center (CC); Duke University; Emory University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bactrim | Levaquin | National Institutes of Health (NIH) | Research | Study | Sulfamethoxazole | Trimethoprim